Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Memantine hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Memantine 20mg tablets
0411000G0AAADAD
|
Memantine hydrochloride (Dementia) | Memantine hydrochloride | Central Nervous System | 258,410 |
|
Memantine 10mg tablets
0411000G0AAAAAA
|
Memantine hydrochloride (Dementia) | Memantine hydrochloride | Central Nervous System | 140,482 |
|
Memantine 10mg/ml oral solution sugar free
0411000G0AAABAB
|
Memantine hydrochloride (Dementia) | Memantine hydrochloride | Central Nervous System | 24,936 |
|
Memantine 20mg orodispersible tablets sugar free
0411000G0AAAGAG
|
Memantine hydrochloride (Dementia) | Memantine hydrochloride | Central Nervous System | 7,392 |
|
Memantine 10mg orodispersible tablets sugar free
0411000G0AAAFAF
|
Memantine hydrochloride (Dementia) | Memantine hydrochloride | Central Nervous System | 3,928 |
|
Memantine 5mg/10mg/15mg/20mg tabs treatment initiation pack
0411000G0AAAEAE
|
Memantine hydrochloride (Dementia) | Memantine hydrochloride | Central Nervous System | 3,045 |
|
Memantine 5mg orodispersible tablets sugar free
0411000G0AAAKAK
|
Memantine hydrochloride (Dementia) | Memantine hydrochloride | Central Nervous System | 1,631 |
|
Ebixa 20mg tablets
0411000G0BBACAD
|
Ebixa | Memantine hydrochloride | Central Nervous System | 292 |
|
Ebixa 5mg/0.5ml pump actuation oral solution
0411000G0BBABAB
|
Ebixa | Memantine hydrochloride | Central Nervous System | 290 |
|
Memantine 5mg/10mg/15mg/20mg orodispersible initiation pack
0411000G0AAAJAJ
|
Memantine hydrochloride (Dementia) | Memantine hydrochloride | Central Nervous System | 217 |
|
Memantine 20mg soluble tablets sugar free
0411000G0AAAIAI
|
Memantine hydrochloride (Dementia) | Memantine hydrochloride | Central Nervous System | 188 |
|
Memantine 10mg soluble tablets sugar free
0411000G0AAAHAH
|
Memantine hydrochloride (Dementia) | Memantine hydrochloride | Central Nervous System | 125 |
|
Ebixa 10mg tablets
0411000G0BBAAAA
|
Ebixa | Memantine hydrochloride | Central Nervous System | 113 |
|
Valios 20mg orodispersible tablets sugar free
0411000G0BFABAG
|
Valios | Memantine hydrochloride | Central Nervous System | 89 |
|
Ebixa tablets treatment initiation pack
0411000G0BBADAE
|
Ebixa | Memantine hydrochloride | Central Nervous System | 49 |
|
Valios 10mg orodispersible tablets sugar free
0411000G0BFAAAF
|
Valios | Memantine hydrochloride | Central Nervous System | 33 |
|
Valios 5mg/10mg/15mg/20mg orodis tablets initiation pack
0411000G0BFACAJ
|
Valios | Memantine hydrochloride | Central Nervous System | 17 |
|
Marixino 20mg tablets
0411000G0BDABAD
|
Marixino | Memantine hydrochloride | Central Nervous System | 7 |
|
Valios 5mg orodispersible tablets sugar free
0411000G0BFADAK
|
Valios | Memantine hydrochloride | Central Nervous System | 5 |
|
Marixino 10mg tablets
0411000G0BDAAAA
|
Marixino | Memantine hydrochloride | Central Nervous System | 2 |
|
Alzhok 20mg soluble tablets
0411000G0BGABAI
|
Alzhok | Memantine hydrochloride | Central Nervous System | 1 |
|
Alzhok 10mg soluble tablets
0411000G0BGAAAH
|
Alzhok | Memantine hydrochloride | Central Nervous System | No data available |
|
Alzhok soluble tablets treatment initiation pack
0411000G0BGACA0
|
Alzhok | Memantine hydrochloride | Central Nervous System | No data available |
|
Mentino 10mg orodispersible tablets
0411000G0BHAAAF
|
Mentino | Memantine hydrochloride | Central Nervous System | No data available |
|
Mentino 20mg orodispersible tablets
0411000G0BHABAG
|
Mentino | Memantine hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.